These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31169893)

  • 1. Durable Control of HIV Infection in the Absence of Antiretroviral Therapy: Opportunities and Obstacles.
    Chun TW; Eisinger RW; Fauci AS
    JAMA; 2019 Jul; 322(1):27-28. PubMed ID: 31169893
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic HIV vaccines: an update.
    Lévy Y
    Curr HIV/AIDS Rep; 2005 Feb; 2(1):5-9. PubMed ID: 16091242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial.
    Ensoli B; Nchabeleng M; Ensoli F; Tripiciano A; Bellino S; Picconi O; Sgadari C; Longo O; Tavoschi L; Joffe D; Cafaro A; Francavilla V; Moretti S; Pavone Cossut MR; Collacchi B; Arancio A; Paniccia G; Casabianca A; Magnani M; Buttò S; Levendal E; Ndimande JV; Asia B; Pillay Y; Garaci E; Monini P;
    Retrovirology; 2016 Jun; 13(1):34. PubMed ID: 27277839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update from Seattle: the 9th Annual Retrovirus Conference.
    Laurence J
    AIDS Read; 2002 Apr; 12(4):132-3, 141. PubMed ID: 12071181
    [No Abstract]   [Full Text] [Related]  

  • 5. Vaccines. From Israel: a T-cell vaccine.
    TreatmentUpdate; 2005; 17(1):11-2. PubMed ID: 17228460
    [No Abstract]   [Full Text] [Related]  

  • 6. The risk of treatment versus the risk of HIV replication.
    Deeks SG
    Lancet; 2006 Jun; 367(9527):1955-6. PubMed ID: 16782465
    [No Abstract]   [Full Text] [Related]  

  • 7. Discontinuation of antiretroviral therapy commenced early during the course of human immunodeficiency virus type 1 infection, with or without adjunctive vaccination.
    Markowitz M; Jin X; Hurley A; Simon V; Ramratnam B; Louie M; Deschenes GR; Ramanathan M; Barsoum S; Vanderhoeven J; He T; Chung C; Murray J; Perelson AS; Zhang L; Ho DD
    J Infect Dis; 2002 Sep; 186(5):634-43. PubMed ID: 12195350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing AIDS but not HIV-1 infection with a DNA vaccine.
    Shen X; Siliciano RF
    Science; 2000 Oct; 290(5491):463-5. PubMed ID: 11183769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV neutralizing antibody titer during structured treatment interruption of highly active antiretroviral therapy.
    Nicastri E; Dori L; Buonomini AR; Tommasi C; De Nardo P; Bellagamba R; Corpolongo A; Montano M; Sordillo P; Volpi A; Sarmati L; Andreoni M
    AIDS; 2012 Jul; 26(11):1451-2. PubMed ID: 22767346
    [No Abstract]   [Full Text] [Related]  

  • 10. AIDS. Boosting immunity to HIV--can the virus help?
    Autran B; Carcelain G
    Science; 2000 Nov; 290(5493):946-9. PubMed ID: 11184735
    [No Abstract]   [Full Text] [Related]  

  • 11. HIV/AIDS research after HAART.
    Gallo RC
    Res Initiat Treat Action; 2005; 11(1):39-41. PubMed ID: 16208818
    [No Abstract]   [Full Text] [Related]  

  • 12. Towards HIV-1 remission: potential roles for broadly neutralizing antibodies.
    Halper-Stromberg A; Nussenzweig MC
    J Clin Invest; 2016 Feb; 126(2):415-23. PubMed ID: 26752643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation and control of the human immunodeficiency virus.
    Stengel RF
    Math Biosci; 2008 Jun; 213(2):93-102. PubMed ID: 18439629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond antiretroviral therapy: early interventions to control HIV-1 infection.
    Gunst JD; Tolstrup M; Søgaard OS
    AIDS; 2017 Jul; 31(12):1665-1667. PubMed ID: 28463884
    [No Abstract]   [Full Text] [Related]  

  • 15. HIV chemotherapy.
    Richman DD
    Nature; 2001 Apr; 410(6831):995-1001. PubMed ID: 11309630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune reconstitution after highly active anti-retroviral treatment of HIV infection.
    Autran B; Carcelain G; Debre P
    Adv Exp Med Biol; 2001; 495():205-12. PubMed ID: 11774568
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune restoration in patients with HIV infection: HAART and beyond.
    Verheggen R
    J Assoc Nurses AIDS Care; 2003; 14(6):76-82. PubMed ID: 14682071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV persistence and the prospect of long-term drug-free remissions for HIV-infected individuals.
    Trono D; Van Lint C; Rouzioux C; Verdin E; Barré-Sinoussi F; Chun TW; Chomont N
    Science; 2010 Jul; 329(5988):174-80. PubMed ID: 20616270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grim news for vaccine.
    AIDS Patient Care STDS; 2002 Oct; 16(10):513-4. PubMed ID: 12442739
    [No Abstract]   [Full Text] [Related]  

  • 20. A Simple Mouse Model for the Study of Human Immunodeficiency Virus.
    Kim KC; Choi BS; Kim KC; Park KH; Lee HJ; Cho YK; Kim SI; Kim SS; Oh YK; Kim YB
    AIDS Res Hum Retroviruses; 2016 Feb; 32(2):194-202. PubMed ID: 26564392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.